Joining an on-going phase III trial for Covid/ards being run in the US mid-stream - but MSB think it isn't price sensitive?
If we get successful results this month from the Covid/Ards trails, given Australia is part of the trial now, one would assume the pathway to this being approved in Australia is a lot easier and quicker - so potentially two immediate markets - but MSB don't think this is price sensitive?
MSB may have the best medical treatments in the world - I hope when the succeed they get some decent corporate communications people.
Ann: Ethics Approval to Treat COVID-19 Patients in Australia, page-80
-
- There are more pages in this discussion • 241 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.058M | 3.436M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 28964 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 29997 | 8 |
View Market Depth
| Last trade - 13.07pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |